Screening of Serum Exosomal miRNAs as Diagnostic Biomarkers for Gastric Cancer Using Small RNA Sequencing

Table 4

KEGG and GO pathway enrichment analysis on cancer-related pathways in which target genes participated.

Id	Num	value	Q value	Per	Ratio
Pathways in cancer	662	3.38E − 05	3.17E − 04	9.761	0.244
MAPK signaling pathway	402	0.03151	9.75E − 02	5.927	0.232
Proteoglycans in cancer	323	1.89E − 09	1.24E − 07	4.763	0.287
Ras signaling pathway	322	1.10E − 06	1.90E − 05	4.748	0.271
cAMP signaling pathway	294	6.27E − 06	7.62E − 05	4.335	0.268
Rap1 signaling pathway	274	0.000354	2.15E − 03	4.04	0.257
Oxytocin signaling pathway	253	1.02E − 06	1.85E − 05	3.73	0.28
Wnt signaling pathway	231	1.82E − 06	5.36E − 05	3.406	0.279
Hepatocellular carcinoma	226	0.000364	2.17E − 03	3.332	0.262
cGMP-PKG signaling pathway	222	0.005342	2.14E − 02	3.273	0.249
Apoptosis	209	0.002303	1.07E − 02	3.082	0.255
FoxO signaling pathway	199	0.000917	4.77E − 03	2.934	0.261
mTOR signaling pathway	196	0.000353	2.15E − 03	2.89	0.266
ErbB signaling pathway	185	4.65E − 08	1.52E − 06	2.728	0.306
Breast cancer	174	0.000154	1.07E − 03	2.566	0.274
Colorectal cancer	166	0.002736	1.23E − 02	2.448	0.26
TNF signaling pathway	154	0.02415	8.06E − 02	2.271	0.247
Pancreatic cancer	150	0.002697	1.23E − 02	2.212	0.263
Cell adhesion molecules (CAMs)	136	0.002295	3.53E − 01	2.005	0.231
NF-kappa B signaling pathway	92	0.003521	7.71E − 01	1.357	0.217